Abiraterone Acetate Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
Condition: Prostate Cancer Intervention: Drug: Neoadjuvant treatment Sponsor: Johns Hopkins Bloomberg School of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2022 Category: Research Source Type: clinical trials
Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)
Condition: Metastatic Castration-resistant Prostate Cancer Interventions: Drug: Niraparib plus Abiraterone Acetate (Nira/AA) combination; Drug: Prednisone/Prednisolone Sponsor: Janssen Research & Development, LLC Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials